% Expired Patents = 25.0

Forward Citations = 0

Loading Chart...

6 inventors (with patents filed for the assignee):

Seung Bum Park (4 out of 10 patents)

Han Kum Park (1 out of 2 patents)

Jonghoon Kim (1 out of 17 patents)

4. Young Jun Lee (1 out of 50 patents)

5. Ja Young Koo (1 out of 2 patents)

6. Wan Sang Cho (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 11584749 - Phosphor-tetrazine compound and use thereof (2023-02-21),

2. 11535627 - Pyrimidine derivative compound, pharmaceutically acceptable salt thereof, preparation process thereof, and pharmaceutical composition using the same (2022-12-27),

3. 11105813 - Method for target protein identification using thermal stability shift-based fluorescence difference in two-dimensional gel electrophoresis (2021-08-31),

4. 10160766 - Benzopyranyl tetracycle compound and pharmaceutical composition having excellent anti-inflammatory effect comprising the same (2018-12-25),

Company Overview

Spark Biopharma, Inc. is a cutting-edge biotechnology company focused on developing innovative treatments for various diseases. Our team of experts is dedicated to pushing the boundaries of science to create groundbreaking therapies that have the potential to improve the lives of patients worldwide. With a strong pipeline of novel compounds, we are committed to advancing precision medicine and delivering hope for the future.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

4 Patents

#765 in Seoul

#2,195 in South Korea

Seoul, South Korea

Spark Biopharma, Inc.

Forward Citations = 0

6 inventors:

Seung Bum Park (4 out of 10 patents)

Han Kum Park (1 out of 2 patents)

Jonghoon Kim (1 out of 17 patents)

4. Young Jun Lee (1 out of 50 patents)

5. Ja Young Koo (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Spark Biopharma, Inc.. Retrieved from https://idiyas.com/company/spark-biopharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]